1. Home
  2. STGW vs QDEL Comparison

STGW vs QDEL Comparison

Compare STGW & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$5.16

Market Cap

1.4B

Sector

N/A

ML Signal

HOLD

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$28.94

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
QDEL
Founded
1980
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STGW
QDEL
Price
$5.16
$28.94
Analyst Decision
Buy
Hold
Analyst Count
6
6
Target Price
$8.46
$39.33
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
1954.71
N/A
EPS
0.06
N/A
Revenue
$2,890,264,000.00
$2,714,400,000.00
Revenue This Year
$4.53
N/A
Revenue Next Year
$7.81
$2.42
P/E Ratio
$93.02
N/A
Revenue Growth
6.75
N/A
52 Week Low
$4.03
$19.50
52 Week High
$7.48
$49.45

Technical Indicators

Market Signals
Indicator
STGW
QDEL
Relative Strength Index (RSI) 42.69 58.46
Support Level $5.51 $28.22
Resistance Level $6.00 $30.00
Average True Range (ATR) 0.20 1.21
MACD -0.06 0.13
Stochastic Oscillator 5.08 64.38

Price Performance

Historical Comparison
STGW
QDEL

About STGW Stagwell Inc.

Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

Share on Social Networks: